학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 7건 | 목록 1~10
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. t.powles@qmul.ac.uk.; Kockx M; HistogeneX N.V, Wilrijk, Belgium.; Rodriguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; Duran I; Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain.; Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Pous AF; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Gravis G; Institut Paoli-Calmettes, Marseille, France.; Herranz UA; Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.; Protheroe A; Department of Medical Oncology, Churchill Hospital, Oxford, UK.; Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France.; Maillet D; Department of Medical Oncology, Hospital Lyon Sud, Lyon, France.; Mendez MJ; Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain.; Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.; Linch M; Department of Medical Oncology, University College London Hospital, London, UK.; Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; van Dam PJ; HistogeneX N.V, Wilrijk, Belgium.; Stanoeva D; HistogeneX N.V, Wilrijk, Belgium.; Daelemans S; HistogeneX N.V, Wilrijk, Belgium.; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.; Mariathasan S; Genentech, San Francisco, CA, USA.; Tea JS; Genentech, San Francisco, CA, USA.; Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Banchereau R; Genentech, San Francisco, CA, USA.; Castellano D; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Robles Barba JJ; Department of Nuclear Medicine PET-CT (IDI) HUB Bellvitge, Spain.; Llobera AS; Department of Nuclear Medicine PET-CT (IDI) HUB Bellvitge, Spain.; Cenzano CG; Department of Nuclear Medicine PET-CT (IDI) HUB Bellvitge, Spain.; Martin Marcuartu JJ; Department of Nuclear Medicine PET-CT (IDI) HUB Bellvitge, Spain.; Martínez NR; Department of Radiology. HUB Bellvitge, Spain.; Paules Villar MJ; Department of Pathological Anatomy HUB Bellvitge, Spain.; Larrañaga CB; Department of General Surgery HUB Bellvitge, Spain.; Inglada AB; Department of Radiation Oncology ICO, Spain.; Campos MC; Department of Medical Oncology ICO, Spain.; Pous AF; Department of Medical Oncology ICO, Spain.; Guzmán MG; Department of Medical Oncology ICO, Spain.; Romera MC; Department of Nuclear Medicine PET-CT (IDI) HUB Bellvitge, Spain.
Publisher: Medknow Country of Publication: India NLM ID: 8901274 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0972-3919 (Print) Linking ISSN: 09740244 NLM ISO Abbreviation: Indian J Nucl Med Subsets: PubMed not MEDLINE
Academic Journal
Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.; Kockx M; CellCarta N V, Wilrijk, Belgium.; Assaf ZJ; Genentech, San Francisco, CA, USA.; van Dam PJ; CellCarta N V, Wilrijk, Belgium.; Rodriguez-Vida A; Hospital del Mar, Barcelona, Spain.; Duran I; Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.; Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Pous AF; Institut Catala d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Gravis G; Institut Paoli-Calmettes, Marseille, France.; Herranz UA; Hospital Clinico Universitario de Santiago, Santiago De Compostela, Spain.; Protheroe A; Churchill Hospital, Oxford, UK.; Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU, Bordeaux, France.; Maillet D; Hospital Lyon SUD, Lyon, France.; Mendez MJ; Reina Sofia University Hospital, Cordoba, Spain.; Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.; Linch M; UCLH, London, UK.; Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Tyson C; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Stanoeva D; CellCarta N V, Wilrijk, Belgium.; Daelemans S; CellCarta N V, Wilrijk, Belgium; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.; Rombouts M; CellCarta N V, Wilrijk, Belgium.; Mariathasan S; Genentech, San Francisco, CA, USA.; Tea JS; Genentech, San Francisco, CA, USA.; Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Sharma S; Natera, Inc., San Carlos, CA, USA.; Aleshin A; Natera, Inc., San Carlos, CA, USA.; Banchereau R; Genentech, San Francisco, CA, USA.; Castellano D; Hospital 12 de Octubre, Madrid, Spain.; Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. Electronic address: thomas.powles1@nhs.net.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Academic Journal
Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rodriguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; Durán I; Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain.; Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Pous AF; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Gravis G; Medical Oncology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Inserm, CNRS, CRCM, Marseille, France.; Herranz UA; Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.; Protheroe A; Maimonides Institute for Biomedical Research oh Cordoba (IMIBIC), Hospital Universitario Reina Sofia, Cordoba, Spain.; Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France.; Maillet D; Department of Medical Oncology, Hospital Lyon Sud, Lyon, France.; Mendez-Vidal MJ; Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain.; Suárez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.; Linch M; Department of Oncology, University College London Cancer Institute, London, UK.; Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Tyson C; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Castellano D; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.; Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. Electronic address: t.powles@qmul.ac.uk.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Academic Journal
Bellmunt Molins J; Medical Oncology, Hospital del Mar, Barcelona, Spain; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: jbellmunt@imim.es.; García-Donas Jiménez J; Medical Oncology, HM Hospitales, Centro Integral Oncológico HM Clara Campal, Madrid, Spain.; Valderrama BP; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.; Virizuela Echaburu JA; Medical Oncology, Hospital Universitario Virgen de Macarena, Sevilla, Spain.; Hernando-Polo S; Medical Oncology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.; Climent Durán MÁ; Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain.; Villa-Guzmán JC; Medical Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.; Arranz Arija JÁ; Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Ostiategui ML; Medical Oncology, Hospital General Universitario de Elda, Alicante, Spain.; Milagro NL; Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain.; González-Del-Alba A; Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.; González BM; Medical Oncology Department, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.; Díaz EG; Oncology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.; Gauna DC; Medical Oncology, CIBER-ONC, Hospital Universitario 12 de Octubre, Madrid, Spain.; Santasusana MD; Medical Oncology, Althaia, Xarxa Assitencial de Manresa, Manresa, Spain.; Herranz UA; Medical Oncology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.; Del Muro Solans XG; Medical Oncology, Institut Català d'Oncologia Hospitalet, IDIBELL, Universitat de Barcelona, Hospitalet de Llobregat, Spain.; Pérez-Gracia JL; Medical Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Vázquez JP; Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.; Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.; Pous AF; Medical Oncology, Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B∙ARGO), IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Academic Journal
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. t.powles@qmul.ac.uk.; Kockx M; HistogeneX N.V., Wilrijk, Belgium.; Rodriguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; Duran I; Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain.; Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Pous AF; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Gravis G; Institut Paoli-Calmettes, Marseille, France.; Herranz UA; Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.; Protheroe A; Department of Medical Oncology, Churchill Hospital, Oxford, UK.; Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France.; Maillet D; Department of Medical Oncology, Hospital Lyon Sud, Lyon, France.; Mendez MJ; Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain.; Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.; Linch M; Department of Medical Oncology, University College London Hospital, London, UK.; Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; van Dam PJ; HistogeneX N.V., Wilrijk, Belgium.; Stanoeva D; HistogeneX N.V., Wilrijk, Belgium.; Daelemans S; HistogeneX N.V., Wilrijk, Belgium.; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.; Mariathasan S; Genentech, San Francisco, CA, USA.; Tea JS; Genentech, San Francisco, CA, USA.; Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Banchereau R; Genentech, San Francisco, CA, USA.; Castellano D; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. t.powles@qmul.ac.uk.; Kockx M; HistogeneX N.V., Wilrijk, Belgium.; Rodriguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; Duran I; Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain.; Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Pous AF; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Gravis G; Institut Paoli-Calmettes, Marseille, France.; Herranz UA; Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.; Protheroe A; Department of Medical Oncology, Churchill Hospital, Oxford, UK.; Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France.; Maillet D; Department of Medical Oncology, Hospital Lyon Sud, Lyon, France.; Mendez MJ; Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain.; Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.; Linch M; Department of Medical Oncology, University College London Hospital, London, UK.; Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; van Dam PJ; HistogeneX N.V., Wilrijk, Belgium.; Stanoeva D; HistogeneX N.V., Wilrijk, Belgium.; Daelemans S; HistogeneX N.V., Wilrijk, Belgium.; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium.; Mariathasan S; Genentech, San Francisco, CA, USA.; Tea JS; Genentech, San Francisco, CA, USA.; Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Banchereau R; Genentech, San Francisco, CA, USA.; Castellano D; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Pous AF
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어